EAHAD chose Prague as its 12th congress destination and more than 2 600 medical experts, pharmacists and community representatives from 80 countries from around the world came to Prague. A record number of EAHAD congress participants was brought to Prague not only thanks to the attractiveness of the city, but also due to advances in genetic therapy, which keep publishing promising results making an opportunity for a quality discussion during the congress.
The main program of the congress took place February 6 – 8, 2019 in 13 halls and meeting rooms, where also discrete sessions with specialists were held separately. These roundtable discussions were hosted by renowned conference partners.
Professor Mike Makris, the President of the association, underlined that Europe is leading the world in research on rare diseases. The President of the EAHAD 2019 Congress, Jan Blatný, expressed his pleasure from hosting the congress in Prague. “I consider this to be sort of a recognition of the Czech Republic and the cooperation of its specialists – physicians, nurses, physiotherapists, insurance companies – all, who take care of patients with bleeding disorders. No country where the care wouldn’t be at a high level would become the host of such a congress.”